Dr. Jagdeep S. Walia is a highly accomplished Clinical Geneticist with over 24 years of experience since earning his MBBS from Guru Nanak Dev University in 1999. He is currently the Head of the Division of Medical Genetics and Director of Research in the Department of Pediatrics at Queen's University and Kingston Health Sciences Centre. His focus has been on diagnosing and managing complex genetic disorders, particularly neurodegenerative lysosomal storage disorders, and he is a recognized expert in gene therapy.

Dr. Walia's educational journey includes a post-doctoral fellowship at the Ontario Cancer Institute, followed by his certification in Medical Genetics through the University of Manitoba. He has combined his clinical and research expertise to push the boundaries of medical genetics, particularly in the areas of gene therapy for disorders like Tay-Sachs and Sandhoff diseases. His work has led to significant advancements in the treatment of these rare genetic disorders, showing promising results in animal models.

As a leading researcher, Dr. Walia has served as the principal investigator for numerous grants, securing substantial funding for his projects. His groundbreaking work includes the development of adeno-associated virus (AAV)-based therapies, which have demonstrated efficacy in animal models of Sandhoff disease. He has published extensively on gene therapy, with his research appearing in leading scientific journals, solidifying his status as a pioneer in the field.

Dr. Walia is also committed to mentoring the next generation of geneticists and researchers. He has supervised numerous students across different levels of academic training and continues to contribute significantly to the academic community. His contributions have earned him recognition through various awards, and he holds memberships in prestigious professional organizations dedicated to advancing medical genetics and pediatric research